showed a trendP = 0.14
Clostridium butyricum MIYAIRI, in a separate randomized trial of 17 patients, showed a trend toward less acute pouchitis compared to placebo (11 vs. 50% P = 0.14) over a period of 24 months ( 40 ).
Clostridium butyricum MIYAIRI, in a separate randomized trial of 17 patients, showed a trend toward less acute pouchitis compared to placebo (11 vs. 50% P = 0.14) over a period of 24 months ( 40 ).
58% in the placebo group, although it did not reach statistical significance ( P = 0.21) ( 41 ). 5-Aminosalicylates There are no data on the efficacy of mesalazine in primary prophylaxis.